CompoAtlas

UTI Plex

UTI Plex, licence 80051306: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Licence holder
Natural Equivalents Incorporated
NPN or DIN-HM
80051306
Status
Inactive licence
Licence date
2 June 2014
Revision date
Not provided
Form
Liquides
Route of administration
Orale
Application type
Homéopathique

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Terebinthina

Source : Huile volatile distillée de l'oléorésine des espèces Pinus

6.0 XNot calculated
Nux vomica

Source : Graines en poudre grossière

6.0 XNot calculated
Equisetum arvense

Source : Tige stérile

6.0 XNot calculated
Pulsatilla

Source : Plante entière

6.0 XNot calculated
Cantharis

Source : Insecte

6.0 XNot calculated
Causticum

Source : Causticum

6.0 XNot calculated
Lycopodium clavatum

Source : Spores

6.0 XNot calculated

Non-medicinal ingredients

Ethanol, Lactose, Aqua

PopulationAgeQuantity per servingFrequency
Adultes et enfantsminimum: 12.0 Année(s)10.0 Goutte(s)3.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Homeopathic remedy used to temporarily relieve symptoms associated with urinary tract infection including involuntary, scantly, smelly and colored urine, and pain and burning sensation when urinating.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80051306

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line